Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Ximino
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Coping strategies and mood profiles in patients with multiple sclerosis.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Functional role of TRP channels in modulating ER stress and Autophagy.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Review of MR elastography applications and recent developments.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Patient perceptions of multiple sclerosis and its treatment.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Time to see the light.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.

Pages